CAS 15384-34-6

(3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-on

Formel: C₅H₈O₅

InChl: InChI=1/C5H8O5/c6-1-2-3(7)4(8)5(9)10-2/h2-4,6-8H,1H2/t2-,3?,4-/m1/s1

SMILES: C([C@@H]1C([C@H](C(=O)O1)O)O)O

(3S, 4R, 5R)-3, 4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one

CAS: 15384-34-6

(3S, 4R, 5R)-3, 4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one

Formel: C₅H₈O₅

Reinheit: ≥95%

Molekulargewicht: 148.11

Ref: 54-OR1112634

D-Lyxono-1,4-lactone

CAS: 15384-34-6

D-Lyxono-1,4-lactone is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.

Formel: C₅H₈O₅

Molekulargewicht: 148.11

Ref: TM-TSW-00226

D-Lyxono-1,4-lactone

CAS: 15384-34-6

Molekulargewicht: 148.11

Ref: 7W-GC1501

D-Lyxono-1,4-lactone

CAS: 15384-34-6

D-Lyxono-1,4-lactone is a 4-deoxy-l-fucose derivative that is a potent inhibitor of bacterial growth. It is a highly effective antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. D-Lyxono-1,4-lactone has been shown to be active against multivorans, including Escherichia coli and Salmonella enterica serovar Typhimurium. This compound was found to be more active than antibiotics such as penicillin and streptomycin. The structure of D-Lyxono-1,4-lactone includes two hydroxamic acid groups that are connected by an acetal linkage to form the benzylidene acetal moiety. The optical enantiomers of this molecule have been characterized using high resolution NMR spectroscopy and magnetic resonance spectroscopy techniques.BR> Dosis: 250

Formel: C₅H₈O₅

Reinheit: Min. 95.0 Area-%

Molekulargewicht: 148.11 g/mol

Ref: 3D-W-201380

D-Lyxono-1,4-lactone

CAS: 15384-34-6

D-Lyxono-1,4-lactone is an inhibitor of the enzyme fucosidase. It competitively inhibits the enzyme, but does not inhibit other hydroxamic acids such as enantiomers of D-lyxono-1,4-lactone. D-Lyxono-1,4-lactone has been used to treat HIV and AIDS because it prevents viral replication by blocking the synthesis of glycoproteins in the virus's envelope. It also has inhibitory effects on tumor cells that are not dependent on fucosidase activity. Magnetic resonance spectroscopy (NMR) studies have shown that d-lyxono-1,4-lactone binds to human liver cells and blocks the binding site for cytotoxic molecules in these cells. The molecular modelling study has demonstrated that d-lyxono 1,4 lactone binds to a specific site on human HLA class II molecule and reduces its

Formel: C₅H₈O₅

Reinheit: (%) Min. 97%

Farbe und Form: Powder

Molekulargewicht: 148.11 g/mol

Ref: 3D-ML05267

(3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one

CAS: 15384-34-6

Formel: C₅H₈O₅

Reinheit: 95%

Molekulargewicht: 148.114

Ref: 10-F053801

D-Lyxono-1,4-lactone

Kontrolliertes Produkt

CAS: 15384-34-6

Applications D-Lyxono-1,4-lactone is used for synthesis of 1,4-dideoxy-1,4-imino-L-arabinitol, a glucosidase inhibitor with in vitro antiviral activity.
References Mitrakou, A., et al.: Diab. Med., 15, 657 (1998), Scott, L., et al.: Drugs, 59, 521 (2000), Vasella, A., et al.: Curr. Opin. Chem. Biol., 6, 619 (2002), Kato, A., et al.: J. Med. Chem., 48, 2036 (2005),

Formel: C₅H₈O₅

Farbe und Form: Neat

Molekulargewicht: 148.11

Ref: TR-L490000

D-Lyxonic acid, g-lactone

CAS: 15384-34-6

Formel: C₅H₈O₅

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 148.1140

Ref: IN-DA00HY6A